Forced expiratory flow in uninfected infants and children born to HIV-infected mothers

A A Colin1, J Sunil Rao, X C Chen

  • 1Division of Pulmonary Medicine, Children's Hospital, Department of Pediatrics/Harvard Medical School, Boston, Massachusetts 02115, USA. colin@tch.harvard.edu

Insights

Infants exposed to maternal HIV, but uninfected, show slightly reduced maximal expiratory flow (V

Area of Science:

  • Pediatric pulmonology
  • Neonatal health
  • Infectious disease epidemiology

Background:

  • Vertical transmission of HIV can impact infant health.
  • The P(2)C(2) HIV study investigates pulmonary and cardiac outcomes in HIV-exposed infants.
  • Understanding lung function in uninfected infants exposed to maternal HIV is crucial.

Purpose of the Study:

  • To test if infants exposed to maternal HIV but uninfected have normal maximal expiratory flow at functional residual capacity (V'max,(FRC)).
  • To compare lung function parameters between HIV-exposed uninfected infants and a healthy cohort.

Main Methods:

  • Utilized rapid thoracic compression to measure V'max,(FRC) in 285 children aged 6-30 months across five U.S. centers.
  • Collected 500 V'max,(FRC) measurements, comparing data to a healthy control group.
  • Analyzed the relationship between V'max,(FRC), height, weight, birth weight, and gestational age.

Main Results:

  • V'max,(FRC) demonstrated a linear relationship with height in both exposed and unexposed infants.
  • The slope of V'max,(FRC) regression did not differ between groups, but the intercept was approximately 20% lower in exposed infants (p < 0.001).
  • Differences in lung function persisted after adjusting for birth weight and gestational age, but potential confounding factors like socioeconomic status and maternal behaviors were noted.

Conclusions:

  • Maternal HIV infection likely has a minimal impact on maximal expiratory flow at functional residual capacity in uninfected infants.
  • Further research is needed to definitively attribute the observed differences to maternal HIV status, considering potential confounders.
  • Multicenter study highlights the importance of controlling for various factors in pediatric respiratory research.

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...